Fractioned dose regimen of sunitinib for patients with gastrointestinal stromal tumor: a pharmacokinetic and treatment efficacy study.

Transl Oncol · 2014 · PMC4225693 · PMID 25389456

Europe PMC DOI

hedged sentence

0.4390

closest p · 8.8× alpha

0.4390

boldest claim

The sentences

did not reach statistical significanceP = .439not close (p > 0.1)

At the same time, the median OS was 20.1 months for the 29 patients who were in the fractioned dose group and 38.9 months for the 26 patients who were in the standard dose group, which also did not reach statistical significance ( P = .439; Figure 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.